Mode
Text Size
Log in / Sign up

Case series identifies 10 persons with Omicron variant infection within 90 days of Delta infection

Case series identifies 10 persons with Omicron variant infection within 90 days of Delta infection
Photo by Navy Medicine / Unsplash
Key Takeaway
Note: Case series suggests possible SARS-CoV-2 reinfection within 90 days, but clinical implications are unknown.

This field report is a descriptive case series of 10 persons across four states who were infected with the SARS-CoV-2 Omicron variant within 90 days of a documented infection with the Delta variant. The report describes the identification of these cases but does not specify the methods for variant confirmation or the clinical setting in detail.

The sole reported finding is that 10 persons were identified with this short-interval reinfection pattern. No data on symptoms, disease severity, hospitalization, or other clinical outcomes were provided. The report does not include any statistical analysis, comparative rates, or effect measures.

Safety and tolerability of the reinfection episodes were not reported. Key limitations include the purely descriptive nature of the report, the small sample size of 10, and the absence of a comparator group or population denominator to estimate reinfection risk. The funding sources and author conflicts of interest were not reported.

For clinical practice, this report serves as an early signal that Omicron variant infection shortly after Delta infection is biologically possible. However, it provides no evidence on how common this is, whether it leads to different clinical outcomes, or what the implications are for immunity or vaccination. Clinicians should be aware of the possibility but await more robust epidemiological studies.

Study Details

EvidenceLevel 5
PublishedApr 2022
View Original Abstract ↓
This report describes 10 people who were infected with the COVID-19 Omicron variant within 90 days of Delta variant infection.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.